Vinge advises Semcon in connection with the offer by Ratos

September 26, 2022 Capital Markets and Public M&A

Vinge is advising Semcon AB (publ) due to the fact that Ratos AB has provided a competing recommended cash offer to the shareholders of Semcon.

The offer price is for SEK 157 per share, which values Semcon at approximately SEK 2 844 million in total.

Vinge’s team primarily consists of Anders Strid, Erik Sjöman and Edin Agic as well as Anna Palmérus who is advising Semcon in relation to competition law issues.


Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024